These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3139386)

  • 21. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter.
    Gerber RC; Paulus HE; Jennrich RI; Lederer M; Bluestone R; Blahd WH; Pearson CM
    J Lab Clin Med; 1974 May; 83(5):778-89. PubMed ID: 4207022
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolism and distribution of gold compounds.
    Gottlieb NL
    J Rheumatol Suppl; 1979; 5():2-6. PubMed ID: 114646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of rheumatoid arthritis with leukopenia to gold salts.
    Gowans JD; Salami M
    N Engl J Med; 1973 May; 288(19):1007-8. PubMed ID: 4633144
    [No Abstract]   [Full Text] [Related]  

  • 25. Myocrisin.
    Capell HA
    Agents Actions Suppl; 1988; 24():158-66. PubMed ID: 3142232
    [No Abstract]   [Full Text] [Related]  

  • 26. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E; Munthe E; Guldal G; Aaseth J
    Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarthritic synergism of combined oral and parenteral chrysotherapy. II. Increased inhibition of activated leukocyte oxygen burst by combined gold action.
    Finkelstein AE; Ladizesky M; Borinsky R; Kohn E; Ginsburg I
    Inflammation; 1988 Aug; 12(4):383-90. PubMed ID: 2844672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatoid arthritis therapy: the slow-acting agents.
    Hardin JG
    Hosp Pract (Off Ed); 1989 Jun; 24(6):163-8, 170, 173-8. PubMed ID: 2566617
    [No Abstract]   [Full Text] [Related]  

  • 30. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA).
    Rau R; Schattenkirchner M; Müller-Fassbender H; Kaik B; Zeidler H
    Clin Rheumatol; 1987 Sep; 6 Suppl 2():43-52. PubMed ID: 3121238
    [No Abstract]   [Full Text] [Related]  

  • 32. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open trial of auranofin (oral gold preparation) in rheumatoid arthritis.
    Malaviya AN; Kabra KR; Kumar A
    J Assoc Physicians India; 1986 Sep; 34(9):625-7. PubMed ID: 3539909
    [No Abstract]   [Full Text] [Related]  

  • 34. Gold levels in serum during the treatment of rheumatoid arthritis with gold sodium thiomalate.
    Palmer DG; Dunckley JV
    Aust N Z J Med; 1973 Oct; 3(5):461-6. PubMed ID: 4204711
    [No Abstract]   [Full Text] [Related]  

  • 35. Gold in the treatment of rheumatoid arthritis -- why, when and how?
    Jessop JD
    J Rheumatol Suppl; 1979; 5():12-7. PubMed ID: 114641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of auranofin: overview and update.
    Gottlieb NL
    Scand J Rheumatol Suppl; 1986; 63():19-28. PubMed ID: 3110942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparative evaluation of parenteral and oral preparations of gold and D-penicillamine in the treatment of rheumatoid nephropathy].
    Chichasova NV; Kanevskaia MZ; Slobodina GA; Varshavskiĭ VA; Krel' OV; Krel' AA
    Ter Arkh; 1991; 63(5):97-101. PubMed ID: 1679571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gold therapy in rheumatoid arthritis.
    Schorn D; Anderson IF
    S Afr Med J; 1975 Aug; 49(37):1505-6. PubMed ID: 125934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.